相关实验视频
Updated: Jan 13, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
药剂师在解决贫困社区持续血糖监测障碍方面的作用
Christ Ange K Cellino1, En-Ling Chen2, Julia Pawelek3
1Clinical Assistant Professor, University at Buffalo, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, 201 Pharmacy Building, Buffalo, New York, 14214.
Journal of the American Pharmacists Association : JAPhA
|January 7, 2026
概括
药剂师可以改善持续血糖监测 (CGM) 的使用和糖尿病管理,特别是在服务不足的人群中. 扩大药剂师领导的CGM计划可以减少健康差异并改善患者的治疗结果.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 健康 公平 卫生 公平
背景情况:
- 持续血糖监测 (CGM) 对糖尿病管理具有显著的好处,包括改善血糖控制和生活质量.
- 然而,由于各种障碍,贫困人口对CGM的公平获取受到限制.
研究的目的:
- 突出药剂师在促进CGM采用和优化其使用方面的作用.
- 通过药剂师主导的干预来确定公平的CGM获取障碍,并提出解决方案.
主要方法:
- 对药剂师主导的CGM干预措施的现有证据的审查.
- 分析服务不足的人群在获得和使用CGM时所面临的障碍.
- 讨论策略,以调整干预措施以满足社会和文化需求.
主要成果:
- 药剂师领导的CGM计划在降低HbA1c和改善时间范围方面表现有前途.
- 有限的研究专门针对服务不足人群的需求.
- 障碍包括成本,数字素养,语言和医疗保健系统的分散.
结论:
- 药剂师领导的CGM倡议对于减少糖尿病差异至关重要.
- 需要量身定制的干预措施来解决服务不足人口的独特需求.
- 扩大这些计划是实现糖尿病护理健康平等的重要一步.
相关概念视频
Diabetes: Management and Pharmacotherapy
858
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
858
Hypoglycemia and Glucagon
822
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
822
SBAR II: Application of SBAR
5.7K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.7K
Errors occurring during blood pressure monitoring
1.3K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
1.3K
Therapeutic Drug Monitoring: Overview and Classification
304
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
304
Oral Hypoglycemic Agents: Biguanides and Glitazones
581
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
581

